BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7282086)

  • 1. [Lethality in children with neuroblastoma (author's transl)].
    Kolb HJ; Schweizer P; Treuner J; Teufel U
    Z Kinderchir; 1981 Jun; 33(2):99-109. PubMed ID: 7282086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroblastoma: biological markers, surgery, and clinical course].
    Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
    Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
    De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
    Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors in neuroblastoma in children].
    Blinov VM; Bukhny AF; Izrail'skaia MA; Dzhalalov KD
    Vopr Onkol; 1984; 30(5):21-31. PubMed ID: 6730411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma in adults: Incidence and survival analysis based on SEER data.
    Esiashvili N; Goodman M; Ward K; Marcus RB; Johnstone PA
    Pediatr Blood Cancer; 2007 Jul; 49(1):41-6. PubMed ID: 16628557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma--a surgical perspective.
    Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
    Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroblastoma in children. Clinical staging and management (author's transl)].
    Haas RJ; Lampert F; Janka G; Helmig M; Holschneider AM; Hecker WC
    Klin Padiatr; 1979 Jul; 191(4):347-55. PubMed ID: 381767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasonable surgery for thoracic neuroblastoma in infants and children.
    Catalano PW; Newton WA; Williams TE; Clatworthy HW; Kilman JW
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):459-64. PubMed ID: 703352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of mediastinal neuroblastoma.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
    Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
    Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
    Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in neuroblastoma.
    Kajanti M; Holsti P
    Ann Clin Res; 1986; 18(3):129-33. PubMed ID: 3740789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for scoliosis in children with neuroblastoma.
    Paulino AC; Fowler BZ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):865-9. PubMed ID: 15708267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant solid tumors in neonates: a study of 71 cases].
    de Bouyn-Icher C; Minard-Colin V; Isapof A; Khuong Quang DA; Redon I; Hartmann O
    Arch Pediatr; 2006 Dec; 13(12):1486-94. PubMed ID: 17137765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of neuroblastoma: analysis of a single institution.
    Izbicki T; Mazur J; Izbicka E
    Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results of neuroblastoma in children in the Republic of Belarus].
    Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
    Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?
    Hero B; Graf N; Simon T; Weirich A; Tröger J; Berthold F
    Klin Padiatr; 2002; 214(4):157-61. PubMed ID: 12165895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.